Immunic Total Assets from 2010 to 2024
IMUX Stock | USD 1.30 0.02 1.56% |
Total Assets | First Reported 2012-12-31 | Previous Quarter 67 M | Current Value 54.3 M | Quarterly Volatility 41.8 M |
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.5 K, Interest Expense of 730.2 K or Other Operating Expenses of 54.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0095 or Price Book Value Ratio of 1.34. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
Immunic | Total Assets |
Latest Immunic's Total Assets Growth Pattern
Below is the plot of the Total Assets of Immunic over the last few years. Total assets refers to the total amount of Immunic assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immunic books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Immunic's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunic's overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 54.3 M | 10 Years Trend |
|
Total Assets |
Timeline |
Immunic Total Assets Regression Statistics
Arithmetic Mean | 69,577,882 | |
Geometric Mean | 41,405,941 | |
Coefficient Of Variation | 72.18 | |
Mean Deviation | 39,423,458 | |
Median | 64,026,000 | |
Standard Deviation | 50,222,242 | |
Sample Variance | 2522.3T | |
Range | 165.9M | |
R-Value | 0.59 | |
Mean Square Error | 1765.8T | |
R-Squared | 0.35 | |
Significance | 0.02 | |
Slope | 6,643,145 | |
Total Sum of Squares | 35311.8T |
Immunic Total Assets History
About Immunic Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Immunic income statement, its balance sheet, and the statement of cash flows. Immunic investors use historical funamental indicators, such as Immunic's Total Assets, to determine how well the company is positioned to perform in the future. Although Immunic investors may use each financial statement separately, they are all related. The changes in Immunic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Immunic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Immunic Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Immunic. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for 2024 | ||
Total Assets | 54.3 M | 81.3 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunic's short interest history, or implied volatility extrapolated from Immunic options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Immunic Correlation against competitors. For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Immunic Stock analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Immunic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. If investors know Immunic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.11) | Return On Assets (0.68) | Return On Equity (1.31) |
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.